Explore the innovative applications of mRNA technologies beyond COVID-19 vaccines. Learn about the potential and future developments in this groundbreaking field.

Moderna’s arch-rival in the mRNA vaccine category, BioNTech, is also developing a personalised cancer vaccine called BNT111, based on four melanoma-associated antigens, in combination with ...